Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
1996-9-12
pubmed:abstractText
Reactive oxygen species play a central role in vascular inflammation and atherogenesis, with enhanced superoxide (O2.-) production contributing significantly to impairment of nitric oxide (.NO)-dependent relaxation of vessels from cholesterol-fed rabbits. We investigated potential sources of O2.- production, which contribute to this loss of endothelium-dependent vascular responses. The vasorelaxation elicited by acetylcholine (ACh) in phenylephrine-contracted, aortic ring segments was impaired by cholesterol feeding. Pretreatment of aortic vessels with either heparin, which competes with xanthine oxidase (XO) for binding to sulfated glycosaminoglycans, or the XO inhibitor allopurinol resulted in a partial restoration (36-40% at 1 muM ACh) of ACh-dependent relaxation. Furthermore, O2.(-)-dependent lucigenin chemiluminescence, measured in intact ring segments from hypercholesterolemic rabbits, was decreased by addition of heparin, allopurinol or a chimeric, heparin-binding superoxide dismutase. XO activity was elevated more than two-fold in plasma of hypercholesterolemic rabbits. Incubation of vascular rings from rabbits on a normal diet with purified XO (10 milliunits/ml) also impaired .NO-dependent relaxation but only in the presence of purine substrate. As with vessels from hypercholesterolemic rabbits, this effect was prevented by heparin and allopurinol treatment. We hypothesize that increases in plasma cholesterol induce the release of XO into the circulation, where it binds to endothelial cell glycosaminoglycans. Only in hypercholesterolemic vessels is sufficient substrate available to sustain the production of O2.- and impair NO-dependent vasorelaxation. Chronically, the continued production of peroxynitrite, (ONOO-) which the simultaneous generation of NO and O2.- implies, may irreversibly impair vessel function.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1310447, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1321628, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1332919, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1552234, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1642693, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1658794, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1793456, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1877295, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1883201, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1934359, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-1998737, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-2316673, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-2432088, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-2448055, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-3409491, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-3499226, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-3568294, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-7543827, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-7564438, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-7600050, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-7649244, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-7687996, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-7735231, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-7810686, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-7814613, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-7898085, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8135741, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8192861, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8215584, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8225022, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8302829, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8365489, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8390482, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8408661, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8424793, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8433427, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8450290, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710942-8618943
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
6
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8745-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits.
pubmed:affiliation
Department of Medicine, University of Alabama at Birmingham 35294, USA.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't